News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
James Davis: Dexamethasone for CRS with teclistamab in R/R Multiple Myeloma
James Davis/X
Mar 5, 2025, 12:14

James Davis: Dexamethasone for CRS with teclistamab in R/R Multiple Myeloma

James Davis, Assistant professor and malignant hematology pharmacist at MUSC Hollings Cancer Center, shared an article he and his colleagues authored on X:

“Hot off the press!

Dexamethasone for CRS with teclistamab. You don’t need toci for grade 1 CRS! great team work.”

Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma

Authors: James Davis et al.

multiple myeloma

 

Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, reshared the post on X, adding:

“Congrats James Davis et al for great Blood Cancer Journal work!

Consider prescribing “pocket dex” for patients following Multiple Myeloma bsAbs. 10mg for Gr1 CRS after ing with team. Easier for pts, easier for centers, works well, and much cheaper than toci!”

Charlotte B. Wagner Christopher Cahoon Donald C. Moore Grace Elsey Hailey Hill Jack Khouri James A. Davis James Davis Jessica McElwee Jordan Snyder Joslyn Rudoni Katelynn Granger Kelley Julian Kimberly M. Green Mikhaila Rice Shebli Atrash Victoria R. Nachar Zahra Mahmoudjafari
Special Coverage
Blog
Jun 27, 2025, 06:06
Douglas Flora: Through The Looking Glass - Sharpening Oncology's Vision
Blog
Jun 27, 2025, 05:56
Dinesh Pendharkar: Roz Nayi Jeet It's a Reflection of What We Witness Every Day
Blog
Jun 27, 2025, 05:53
ESMO - Early Registration is Open for the Molecular Analysis for Precision Oncology Congress 2025
Dialogues
Jun 27, 2025, 05:47
Top Biotechs at ASCO: Marwan Fakih on a Novel CTLA-4 Approach in MSS Colorectal Cancer
Career
Jun 27, 2025, 05:43
Kerry Burnstein Was Awarded J. Enloe Dodson Chair in Cancer Research - Sylvester Comprehensive Cancer Center
Blog
Jun 27, 2025, 05:35
The Message from ASCO 2025 Is Clear: Oncology Is Evolving Fast - NCODA
Dialogues
Jun 27, 2025, 05:35
Top Biotechs at ASCO: Kohkan Shamsi on How RadMD Delivers Imaging for Cancer Drug Development
Blog
Jun 27, 2025, 05:26
Lucas de Toca: Eliminating Cervical Cancer Can Be a Reality
Dialogues
Jun 27, 2025, 05:23
Top Biotechs at ASCO: Ying Huang on Carvykti’s 5-Year Data and Expanding CAR-T Therapy in Myeloma
Blog
Jun 27, 2025, 05:19
Hilary Robbins Presented at the G7 Cancer Conference on Poor Prognosis Cancers - IARC
Insight
Jun 27, 2025, 05:17
E. Shyam P. Reddy: Synthetic Protein Jams up Diseased Cells
Blog
Jun 27, 2025, 04:58
Michael Jefford Congratulated All 2025 FMASCC Fellows